BR0007894A - Emprego de moxonidina para tratamento apósinfarto cardìaco - Google Patents
Emprego de moxonidina para tratamento apósinfarto cardìacoInfo
- Publication number
- BR0007894A BR0007894A BR0007894-8A BR0007894A BR0007894A BR 0007894 A BR0007894 A BR 0007894A BR 0007894 A BR0007894 A BR 0007894A BR 0007894 A BR0007894 A BR 0007894A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- moxonidine
- myocardial infarction
- cardiac infarction
- infarction
- Prior art date
Links
- WPNJAUFVNXKLIM-UHFFFAOYSA-N Moxonidine Chemical compound COC1=NC(C)=NC(Cl)=C1NC1=NCCN1 WPNJAUFVNXKLIM-UHFFFAOYSA-N 0.000 title abstract 4
- 229960003938 moxonidine Drugs 0.000 title abstract 4
- 206010061216 Infarction Diseases 0.000 title abstract 2
- 230000007574 infarction Effects 0.000 title abstract 2
- 230000000747 cardiac effect Effects 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 2
- 208000010125 myocardial infarction Diseases 0.000 abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 206010000891 acute myocardial infarction Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000003680 myocardial damage Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Details Of Spanners, Wrenches, And Screw Drivers And Accessories (AREA)
- Heat Treatment Of Articles (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fire-Extinguishing Compositions (AREA)
- Farming Of Fish And Shellfish (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Abstract
Patente de Invenção: "EMPREGO DE MOXONIDINA PARATRATAMENTO APóS INFARTO CARDìACO". é descrito oemprego de moxonidina e seus sais ácidos de adiçãofisiologicamente compatíveis para produção de preparaçõesfarmacêuticas para tratamento de danos do miocárdio causadospor infarto do miocárdio. Preparações farmacêuticas contendomoxonidina e seus sais ácidos de adição fisiologicamentecompatíveis, são apropriadas para emprego aqui tendo em vista otratamento do infarto agudo do miocárdio elou tratamentopós-infarto do miocárdio.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19903780 | 1999-02-01 | ||
PCT/EP2000/000655 WO2000045820A1 (de) | 1999-02-01 | 2000-01-28 | Verwendung von moxonidin zur behandlung nach herzinfarkt |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0007894A true BR0007894A (pt) | 2001-10-30 |
Family
ID=7895940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0007894-8A BR0007894A (pt) | 1999-02-01 | 2000-01-28 | Emprego de moxonidina para tratamento apósinfarto cardìaco |
Country Status (26)
Country | Link |
---|---|
US (1) | US7041303B2 (pt) |
EP (1) | EP1150680B1 (pt) |
JP (1) | JP4686027B2 (pt) |
KR (1) | KR20010092793A (pt) |
CN (1) | CN1166363C (pt) |
AT (1) | ATE286731T1 (pt) |
AU (1) | AU774855B2 (pt) |
BR (1) | BR0007894A (pt) |
CA (1) | CA2361600C (pt) |
CZ (1) | CZ20012615A3 (pt) |
DE (2) | DE10003771A1 (pt) |
DK (1) | DK1150680T3 (pt) |
ES (1) | ES2235829T3 (pt) |
HK (1) | HK1042650B (pt) |
HU (1) | HUP0105210A3 (pt) |
IL (1) | IL144621A (pt) |
NO (1) | NO321061B1 (pt) |
NZ (1) | NZ513869A (pt) |
PL (1) | PL195124B1 (pt) |
PT (1) | PT1150680E (pt) |
RU (1) | RU2261097C2 (pt) |
SK (1) | SK10082001A3 (pt) |
TR (1) | TR200102221T2 (pt) |
UA (1) | UA67822C2 (pt) |
WO (1) | WO2000045820A1 (pt) |
ZA (1) | ZA200105827B (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102850331B (zh) * | 2012-09-17 | 2015-05-20 | 符爱清 | 一种化合物的制备方法 |
CN103483268B (zh) * | 2013-09-17 | 2015-10-14 | 常州大学 | 一种4,6-二氯-2-甲基-5-硝基嘧啶的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3739779A1 (de) * | 1987-11-24 | 1989-06-08 | Beiersdorf Ag | Pharmazeutische praeparate |
AU3233197A (en) * | 1996-06-06 | 1998-01-05 | Eli Lilly And Company | Formulation and method for treating congestive heart failure |
-
2000
- 2000-01-28 NZ NZ513869A patent/NZ513869A/xx unknown
- 2000-01-28 JP JP2000596940A patent/JP4686027B2/ja not_active Expired - Fee Related
- 2000-01-28 CZ CZ20012615A patent/CZ20012615A3/cs unknown
- 2000-01-28 SK SK1008-2001A patent/SK10082001A3/sk unknown
- 2000-01-28 CN CNB008032440A patent/CN1166363C/zh not_active Expired - Fee Related
- 2000-01-28 IL IL14462100A patent/IL144621A/en not_active IP Right Cessation
- 2000-01-28 PT PT00902638T patent/PT1150680E/pt unknown
- 2000-01-28 TR TR2001/02221T patent/TR200102221T2/xx unknown
- 2000-01-28 AT AT00902638T patent/ATE286731T1/de not_active IP Right Cessation
- 2000-01-28 DK DK00902638T patent/DK1150680T3/da active
- 2000-01-28 UA UA2001075408A patent/UA67822C2/uk unknown
- 2000-01-28 BR BR0007894-8A patent/BR0007894A/pt not_active IP Right Cessation
- 2000-01-28 EP EP00902638A patent/EP1150680B1/de not_active Expired - Lifetime
- 2000-01-28 KR KR1020017009232A patent/KR20010092793A/ko not_active Application Discontinuation
- 2000-01-28 DE DE10003771A patent/DE10003771A1/de not_active Withdrawn
- 2000-01-28 HU HU0105210A patent/HUP0105210A3/hu unknown
- 2000-01-28 CA CA002361600A patent/CA2361600C/en not_active Expired - Fee Related
- 2000-01-28 ES ES00902638T patent/ES2235829T3/es not_active Expired - Lifetime
- 2000-01-28 AU AU24404/00A patent/AU774855B2/en not_active Ceased
- 2000-01-28 DE DE50009220T patent/DE50009220D1/de not_active Expired - Lifetime
- 2000-01-28 RU RU2001121019/14A patent/RU2261097C2/ru not_active IP Right Cessation
- 2000-01-28 PL PL00350559A patent/PL195124B1/pl not_active IP Right Cessation
- 2000-01-28 WO PCT/EP2000/000655 patent/WO2000045820A1/de not_active Application Discontinuation
-
2001
- 2001-07-16 ZA ZA200105827A patent/ZA200105827B/en unknown
- 2001-07-31 NO NO20013753A patent/NO321061B1/no unknown
- 2001-07-31 US US09/917,858 patent/US7041303B2/en not_active Expired - Fee Related
-
2002
- 2002-05-31 HK HK02104090.9A patent/HK1042650B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0003173A2 (hu) | A GLP-1 vagy analógjainak alkalmazása szívizominfarktus kezelésére használható gyógyszerkészítmények előállítására | |
SE8804629D0 (sv) | New therapeutically active compounds | |
RU2002109240A (ru) | Применение ретигабина для невропатических болей | |
ATE182581T1 (de) | Metalloproteinase-inhibitoren | |
PT1227806E (pt) | Formulacao farmaceutica contendo tolterodina e sua utilizacao | |
BRPI0008228B8 (pt) | composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes | |
ATE322878T1 (de) | Biotin enthaltende galenische formulierung | |
WO2001047913A3 (de) | Substituierte n-benzyl-indol-3-yl- glyoxylsäure-derivate antitumorwirkung | |
DE60220055D1 (de) | 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden | |
HUP0302288A2 (hu) | Kardiális aritmiák kezelésében alkalmazható oxa-biszpidin-származék és az ezt tartalmazó gyógyszerkészítmények | |
RU2001118854A (ru) | Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний | |
NO912414L (no) | Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling. | |
HUP9802897A2 (hu) | Optikailag aktív piridil-4H-1,2,4-oxadiazin-származék, annak alkalmazása vaszkuláris betegségek kezelésére, valamint ilyen származékot hatóanyagként tartalmazó gyógyászati készítmény | |
BR0007894A (pt) | Emprego de moxonidina para tratamento apósinfarto cardìaco | |
RU2001120358A (ru) | Применение ингибиторов натрий-водород-антипортера для получения лекарственного средства для ингибирования обусловленных возрастом дисфункций органов, обусловленных возрастом заболеваний и для продления жизни | |
HRP20050815A2 (en) | 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound | |
AR026631A1 (es) | ''3-4-dihidroquinazolinas 5,6-disustituidas'' | |
BR0303384A (pt) | Citalopram e seus usos no tratamento de pressão sanguìnea elevada | |
HUP0402118A2 (hu) | Propionil-L-karnitin vagy gyógyászatilag elfogadható sója, alkalmazása peyronie-betegség kezelésére szánt gyógyászati készítmény előállítására | |
SE9902674D0 (sv) | New composition | |
IT1279386B1 (it) | 1,5 derivati di 7a-metilperidroinden-3a-oli, attivi sul sistema cardiovascolare, procedimenti per la loro preparazione e composizioni | |
AR003117A1 (es) | El uso de derivado de aminotetralina para la preparacion de composiciones farmaceuticas para la terapia de enfermedades cardiovasculares y dichascomposiciones farmaceuticas. | |
TH51071A3 (th) | ตัวยับยั้งเอนไซม์ย่อยสลายโปรตีน | |
RU2001123675A (ru) | Средство бальзам "ГРААЛЬ" для лечения сердечно-сосудистой системы и заболеваний крови человека | |
RU2000105080A (ru) | Препарат для лечения гриппа |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DA INT.CL: A61K 31/506, C07D 403/12, A61P 9/10 Ipc: A61K 31/506 (2009.01), A61P 9/10 (2009.01) |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFERIDO O PEDIDO COM BASE NOS ARTIGOS 8O, 13, 24 E 25 DA LPI. |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B25D | Requested change of name of applicant approved |
Owner name: ABBOTT PRODUCTS GMBH (DE) |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 15A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2291 DE 02/12/2014. |